Both DMRs mapped to the HLA-DRB1 gene and comprised 19 consecutive CpGs, encompassing exon 2, which were hypomethylated in MS patients (Fig. 2a). This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.